420 related articles for article (PubMed ID: 33740123)
1. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
[TBL] [Abstract][Full Text] [Related]
2. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
[TBL] [Abstract][Full Text] [Related]
4. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
[TBL] [Abstract][Full Text] [Related]
5. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
[No Abstract] [Full Text] [Related]
6. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.
Dover AR; Ritchie SA; McKnight JA; Strachan MWJ; Zammitt NN; Wake DJ; Forbes S; Stimson RH; Gibb FW
Diabet Med; 2021 Jan; 38(1):e14374. PubMed ID: 32740984
[TBL] [Abstract][Full Text] [Related]
7. Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study.
Yin W; Liu Y; Hu H; Sun J; Liu Y; Wang Z
PLoS One; 2022; 17(9):e0275251. PubMed ID: 36174028
[TBL] [Abstract][Full Text] [Related]
8. Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India.
Khare J; Jindal S
Prim Care Diabetes; 2022 Dec; 16(6):775-779. PubMed ID: 33419712
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of the flash glucose monitoring system in type 1 diabetics: An mHealth ally in times of COVID-19.
Cervantes-Torres L; Romero-Blanco C
J Clin Nurs; 2023 Jul; 32(13-14):3840-3851. PubMed ID: 36071646
[TBL] [Abstract][Full Text] [Related]
11. Did social isolation during the SARS-CoV-2 epidemic have an impact on the lifestyles of citizens?
Ferrante G; Camussi E; Piccinelli C; Senore C; Armaroli P; Ortale A; Garena F; Giordano L
Epidemiol Prev; 2020; 44(5-6 Suppl 2):353-362. PubMed ID: 33412829
[TBL] [Abstract][Full Text] [Related]
12. Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range.
van der Linden J; Welsh JB; Hirsch IB; Garg SK
Diabetes Technol Ther; 2021 Mar; 23(S1):S1-S7. PubMed ID: 33470892
[No Abstract] [Full Text] [Related]
13. Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.
Haynes SC; Kompala T; Neinstein A; Rosenthal J; Crossen S
J Diabetes Sci Technol; 2021 Sep; 15(5):986-992. PubMed ID: 33719622
[TBL] [Abstract][Full Text] [Related]
14. Home telemonitoring for type 2 diabetes: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(24):1-38. PubMed ID: 23074529
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 on Health Economics and Technology of Diabetes Care: Use Cases of Real-Time Continuous Glucose Monitoring to Transform Health Care During a Global Pandemic.
Garg S; Norman GJ
Diabetes Technol Ther; 2021 Mar; 23(S1):S15-S20. PubMed ID: 33449822
[No Abstract] [Full Text] [Related]
16. Lockdown effects on Parkinson's disease during COVID-19 pandemic: a pilot study.
Falla M; Dodich A; Papagno C; Gober A; Narduzzi P; Pierotti E; Falk M; Zappini F; Colosimo C; Turella L
Acta Neurol Belg; 2021 Oct; 121(5):1191-1198. PubMed ID: 34212285
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
[TBL] [Abstract][Full Text] [Related]
18. Estimating The Possible Role Of Testing Capacity And Social Distancing In Predicting The Growth Rate Of Daily Covid-19 Cases.
Haroon MZ; Khan SA; Khan SA; Khan KA; Khan AN; Farooq MU; Aurangzeb A
J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S686-S690. PubMed ID: 33754532
[TBL] [Abstract][Full Text] [Related]
19. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
